Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
SomaLogic Announces Appointment of Adam Taich as Chief Business Officer
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has […]
Karyopharm Promotes Sohanya Cheng to Chief Commercial Officer
Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that […]
Caris Life Sciences Announces Appointment of Rob Clark as Chief Communications Officer
Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced today […]
Azenta Life Sciences Names Matthew McManus Chief Operating Officer
Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th. In […]
Elekta to Appoint Tobias Hägglöv as Chief Financial Officer
Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer […]
Samsara Therapeutics Establishes Scientific Advisory Board
Samsara Therapeutics Inc. (Samsara), a discovery-stage biotech with a world-leading screening platform for inducers of […]
Anthos Therapeutics Appoints David McIntyre as Chief Financial Officer
Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today […]
Onxeo Appoints Julien Miara as New Interim CEO
Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), (“Onxeo” or “the Company”), a […]
Sobi Continues the R&D Transformation - Anders Ullman Appointed New Head of R&D
Anders Ullman, M.D., Ph.D., currently a member of the Board of Directors of Sobi, will […]
EmpiRx Health Announces Jennifer Ferrang as Chief Growth Officer
EmpiRx Health, the industry’s only value-based pharmacy benefit manager (PBM), today announced it has appointed Jennifer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more